Young Living Essential Oils Corporate

Warning LetterOpen

Mary B. Young Co-Founder and Chief Executive Officer Young Living Essential Oils Corporate 3125 W Executive Pkwy Lehi , UT 84043 United StatesIssued Jun 10, 2022Office of Human and Animal Food Operations – West Division 4

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations4

Issue DateJun 10, 2022

Product TypeDrugs

StatusOpen

Letter Details

Firm: Young Living Essential Oils Corporate
Location: Mary B. Young Co-Founder and Chief Executive Officer Young Living Essential Oils Corporate 3125 W Executive Pkwy Lehi , UT 84043 United States
FEI Number: N/A
Country: United States
Issue Date: June 10, 2022
Issuing Office: Office of Human and Animal Food Operations – West Division 4
Product Type: Drugs
Status: Open

Summary

Young Living Essential Oils Corporate was cited for marketing essential oils, vitality products, CBD products, and other items as drugs without FDA approval and with therapeutic claims that rendered them misbranded. The FDA found that Young Living promoted these products through independent consultants on social media and company websites (youngliving.com and naturesultra.com) with disease treatment and health benefit claims, causing them to meet the definition of unapproved new drugs under federal law. The company failed to ensure that marketing materials complied with drug regulations, instead allowing paid consultants to make unauthorized therapeutic claims across multiple platforms including Instagram and Facebook.

Young Living Essential Oils Corporate FDA Warning Letter, June 10, 2022